Skip to content
Directory

Portfolio companies.
21,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 22 of 23
PDS Biotechnology
EMV Capital Evergreen Fund
United States
Active
Sector
Biotech
InvestorEMV Capital
Entry
2014
Hold
12yr
Pepkon
Aloe Environment Fund III
France
Active
Sector
Biotech
InvestorAloe Private Equity
Entry
2019
Hold
7yr
PEPperPRINT
HTGF I
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2010
Hold
16yr
PeptiSystems
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2019
Hold
7yr
Pergamum
Rosetta Capital IV
Sweden
Active
Sector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr
Phaeosynt GmbH
NBank Capital Beteiligungsfonds
Germany
Active
Sector
Biotech
InvestorNBank Capital
Entry
2025
Hold
1yr
Pharmability
Almi Invest (Regional funds)
Sweden
Active
Sector
Biotech
InvestorAlmi Invest
Entry
2020
Hold
6yr
Pharmacelera
Inveready Biotech III
Spain
Active
Sector
Biotech
InvestorInveready Asset Management
Entry
2026
Hold
0yr
PharmEste
Principia Fund
Italy
Active
Sector
Biotech
InvestorPrincipia SGR
Entry
2007
Hold
19yr
Pixelgen
Navigare Ventures
Sweden
Active
Sector
Biotech
InvestorNavigare Ventures
Entry
2022
Hold
4yr
Pixelgen Technologies
Industrifonden Evergreen
Sweden
Active
Sector
Biotech
InvestorIndustrifonden
Entry
2023
Hold
3yr
PL BioScience
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
Germany
Active
Sector
Biotech
InvestorD11Z. Ventures
Entry
2021
Hold
5yr
Polyphron
Vento Fund II
United States
Active
Sector
Biotech
InvestorVento
Entry
2025
Hold
1yr
Portal Biotech
Earlybird Health
United Kingdom
Active
Sector
Biotech
InvestorEarlybird Venture Capital
Entry
2025
Hold
1yr
PreOmics
HTGF III
Germany
Active
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2017
Hold
9yr
Priothera Ltd.
HealthCap VII
Ireland
Active
Sector
Biotech
InvestorHealthCap
Entry
2020
Hold
6yr
Prokarium
Flerie Invest
United Kingdom
Active
Sector
Biotech
InvestorFlerie
Entry
2014
Hold
12yr
Promatix
ALSA Ventures European Biotechnology Fund
UK
Active
Sector
Biotech
InvestorALSA Ventures
Entry
2021
Hold
5yr
ProteomEdge
Navigare Ventures
Sweden
Active
Sector
Biotech
InvestorNavigare Ventures
Entry
2025
Hold
1yr
Proteos Biotech
Tresmares Private Equity Fund II
Spain
Active
Sector
Biotech
InvestorTresmares Capital
Entry
2023
Hold
3yr
ProTgen
Boehringer Ingelheim Venture Fund
United States
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2024
Hold
2yr
PsiOxus Therapeutics
Rosetta Capital V
UK
Active
Sector
Biotech
InvestorRosetta Capital
Entry
2021
Hold
5yr
Pulmobiotics
Invivo Ventures
Spain
Active
Sector
Biotech
InvestorInvivo Partners
Entry
2020
Hold
6yr
QUANTRO Therapeutics
Boehringer Ingelheim Venture Fund
Austria
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2020
Hold
6yr
R1 Therapeutics
Abingworth Bioventures IX
US
Active
Sector
Biotech
InvestorAbingworth
Entry
2026
Hold
0yr
Rampart Biosciences
HealthCap VIII
United States
Active
Sector
Biotech
InvestorHealthCap
Entry
2023
Hold
3yr
Rarity Bioscience
Navigare Ventures
Sweden
Active
Sector
Biotech
InvestorNavigare Ventures
Entry
2022
Hold
4yr
Rathlin Therapeutics
Columbus Life Sciences Fund IV
United Kingdom
Active
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2023
Hold
3yr
Re-Vana Therapeutics Ltd
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2016
Hold
10yr
Recursion
Mubadala Capital Other Investments
United States
Active
Sector
Biotech
InvestorMubadala Capital
Entry
–
Recurv Pharma, Inc.
TVM Life Science Innovation
United States
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2023
Hold
3yr
ReNewVax
QUBIS Ltd
UK
Active
Sector
Biotech
InvestorQubis
Entry
2025
Hold
1yr
Repron Therapeutics
Claris Biotech I
Italy
Active
Sector
Biotech
InvestorClaris Ventures SGR
Entry
2023
Hold
3yr
Reservoir Neuroscience
KIZOO Evergreen (Balance Sheet)
United States
Active
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2024
Hold
2yr
Retein
Navigare Ventures
Sweden
Active
Sector
Biotech
InvestorNavigare Ventures
Entry
2023
Hold
3yr
RheumaLogics
Novo Holdings Seed Investments
Denmark
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2024
Hold
2yr
Ribonexus
AFB Fund II
France
Active
Sector
Biotech
InvestorAdBio Partners
Entry
2021
Hold
5yr
RiboX Therapeutics
Boehringer Ingelheim Venture Fund
China
Active
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2021
Hold
5yr
Riva Therapeutics
Novo Holdings Venture Investments
United States
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2022
Hold
4yr
RoukenBio
NorthEdge Fund III
United Kingdom
Active
Sector
Biotech
InvestorNorthEdge Capital
Entry
2023
Hold
3yr
RQ Biotechnology
LifeArc Ventures
UK
Active
Sector
Biotech
InvestorLifeArc
Entry
2022
Hold
4yr
Rubedo Life Sciences
Oscar & Paul Venture Capital Fund I
United States
Active
Sector
Biotech
InvestorOscar & Paul (Beiersdorf Venture Capital)
Entry
2024
Hold
2yr
Ruby Bio
Nucleus Capital II
United States
Active
Sector
Biotech
InvestorNucleus Capital
Entry
2025
Hold
1yr
Sable Bio
MMC Ventures EIS Fund
UK
Active
Sector
Biotech
InvestorMMC Ventures
Entry
2025
Hold
1yr
SACRA Therapeutics
Eir Ventures I
Sweden
Active
Sector
Biotech
InvestorEir Ventures
Entry
2021
Hold
5yr
Sangon Biotech
Novo Holdings Growth Investments
China
Active
Sector
Biotech
InvestorNovo Holdings
Entry
2023
Hold
3yr
Sarkana Pharma, Inc.
TVM Life Science Innovation
Canada
Active
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2021
Hold
5yr
ScandiBio
Navigare Ventures
Sweden
Active
Sector
Biotech
InvestorNavigare Ventures
Entry
2018
Hold
8yr
Scripta Therapeutics
Parkwalk Opportunities EIS Fund
UK
Active
Sector
Biotech
InvestorParkwalk Advisors
Entry
2025
Hold
1yr
Sengenics
Summa Equity Fund II
Singapore
Active
Sector
Biotech
InvestorSumma Equity
Entry
2020
Hold
6yr
Previous1…20212223Next